What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings? — BMY +0.60 · News Impact Screener

What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings? — BMY +0.60 · News Impact Screener

Which stocks this story touches

How each ticker is affected

BMY+0.60
More positive than 77% of ticker scores this week
Noted for having an excellent earnings record with significant average surprises in recent quarters.
JNJ+0.40
More positive than 65% of ticker scores this week
Reported a beat on earnings estimates and raised full-year sales expectations.

Connected tickers

BMY→LLYcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
BMY→MRKcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
LLY→MRKcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
BMY→ABBVcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
BMY→GILDcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
LLY→ABBVcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
LLY→GILDcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
MRK→ABBVcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
MRK→GILDcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.
ABBV→GILDcompetitor
+0.60
More positive than 13% of relationship scores this week
[mutual] Both are listed as pharma/biotech companies in the medical sector reporting quarterly results.